MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Multi-Sequence MRI-Based Machine Learning Model for Differentiating Parkinson Disease (PD) from Multiple System Atrophy (MSA)

    Y. Wang, N. He, M. Haacke, F. Yan, G. Yang, P. Lewitt (Shanghai, China)

    Objective: To develop a multi-sequence MRI-based machine learning model differentiating PD from MSA. Background: MRI protocols capable of distinguishing PD from MSA are greatly needed.…
  • 2026 International Congress

    Gelsolin and Secretogranin-3 induce Parkinsonian features in rodent models.

    R. Raghu, S. Choudhury, P. Alladi (Bengaluru, India)

    Objective: To study the pathogenic potential of Gelsolin (GSN) and Secretogranin-3 (SCG3) in inducing Parkinsonian features. Background: Parkinson’s disease (PD) is a complex neurodegenerative disorder…
  • 2026 International Congress

    The Cats-and-Dogs Test Predicts Cognitive Impairment in Parkinson’s Disease in a Diverse Population

    KC. Dey, D. Mair, T. Zannat, A. Zirra, E. Camboe, E. Bhadra, ABS. Haque, R. Weil, D. Gallagher, C. Budu, T. Haque, S. Hussain-Ali, N. Mukadam, A. Habib, CR. Marshall, AJ. Noyce, S. Waters (London, United Kingdom)

    Objective: To determine whether the Cats-and-Dogs visuoperceptual task (CnD) predicts cognitive impairment (CI) in Parkinson’s disease (PD) in a diverse population in East London and…
  • 2026 International Congress

    Postural Sway Frequencies in Isolated REM Sleep Behavior Disorder Might Indicate Subtle Motor Impairments as Prodromal Marker of Parkinson’s Disease

    D. Engel, P. Carlson-Kuhta, M. Lim, H. Hameed, K. Ehgoetz Martens, F. Horak, M. Mancini, M. Sommerauer (Bonn, Germany)

    Objective: In this preliminary study, we aimed to compare postural sway between individuals with early, untreated Parkinson’s disease (PD), individuals with isolated REM sleep behavior…
  • 2026 International Congress

    Clinical and Patient-Reported Outcomes in Patients With and Without Severe Bradykinesia According to Sensor Measurements

    D. von Below, S. Wallerstedt, F. Bergquist (Gothenburg, Sweden)

    Objective: To explore clinical and patient-reported outcomes in patients with and without severe sensor-measured bradykinesia in patients with Parkinson’s disease (PD). Background: Parkinson's disease (PD)…
  • 2026 International Congress

    Basal Ganglia Pathway Recruitment Determines Bidirectional Bradykinesia Modulation by DBS in Humans

    P. Navratil, A. Schmidt, H. Eldebakey, N. Rajamani, V. Odekerken, R. de Bie, C. Zhang, K. Kimura, G. Abbas, R. Peach, J. Roothans, J. Volkmann, F. Lange, M. Reich (Wuerzburg, Germany)

    Objective: Understanding the role of distinct basal ganglia pathways in DBS-elicited modulation of bradykinesia across its indications. Background: Opposing bidirectional effects of selective pathway stimulation…
  • 2026 International Congress

    Optimizing Identification of Hyposmia for Parkinson’s Disease Risk Screening: Results from the Healthy Brain Aging Study

    C. Theyer, S. Leiter, CG. Horlings, I. Egner, F. Krismer, S. Meyer, A. Noyce, E. Tolosa, A. Garrido, D. Pilco-Janeta, S. Ghosh, K. Rege, R. Krüger, M. Marti, V. Satagopam, B. Mollenhauer, C. Trenkwalder, K. Seppi, W. Poewe, P. Mahlknecht (Innsbruck, Austria)

    Objective: To evaluate whether questionnaire-based variables can identify individuals with Olfactory Dysfunction (OD), thereby supporting a targeted preselection approach for Parkinson’s Disease (PD) screening. Background:…
  • 2026 International Congress

    When Presynaptic Stimulation is Not Enough: Severe Biphasic Dyskinesia on LECIG Reversed by Postsynaptic Apomorphine Rescue

    A. Alonso Cánovas, I. Parees Moreno, C. Moreno Lopez, A. Patiño Paton, EJ. Martinez Esteban, P. Perez Torre, JL. López Sendón, JC. Martinez Castrillo (Madrid, Spain)

    Objective: To report an exceptional case of advanced Parkinson’s disease (PD) where levodopa/carbidopa/entacapone intestinal gel (LECIG) failed to provide adequate motor control, ultimately requiring a…
  • 2026 International Congress

    Barriers to Disease-Modifying Clinical Trials in Parkinson’s Disease: A Survey of Clinicians and Researchers Involved in Clinical Trials

    J A. de Marcaida, K. Kearney, S. Mccarthy, G. Woolery, K. Hespeler, M. Hespeler, S. Dewitte, A. Espay (Vernon, USA)

    Objective: To assess clinician and researcher views on the integration of biomarkers and biological subtyping in PD trials and perceived barriers to recruitment and completion.…
  • 2026 International Congress

    LRRK2 Mutation Spectrum and Association Study in a Multi-ethnic Cohort of Malaysian Parkinson’s Disease Patients

    K. Lim, J. Lim, M. Periñan, Y. Tay, T. Toh, L. Lit, A. Khairul Anuar, H. Ding, K. Ibrahim, A. Mawardi, Y. Chia, J. Ooi, T. Lim, J. Schee, Y. Beh, L. Screven, S. Bandres-Ciga, S. Lim, A. Tan, A. Ahmad-Annuar (Kuala Lumpur, Malaysia)

    Objective: To systematically characterize the spectrum, haplotypes, and cumulative burden of LRRK2 variants and determine their associations with PD risk in the multi-ancestry Malaysian population.…
  • « Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley